Abstract
Importance Debate about whether high intake of dietary saturated fat causes coronary heart disease (the lipid hypothesis) is ongoing.
Objective Test the lipid hypothesis and our “fat-soluble vitamin hypothesis” with global cohort data
Design Using Global Burden of Disease (GBD) data on cardiovascular disease deaths/100k/year, ages 15-69 years old in male and female cohorts (CVD) and dietary and other CVD risk factors, we formatted and population weighted data from 195 countries.
Setting Worldwide
Participants The formatted 7846 rows of data (cohorts) represented about 1 million people each, totaling about 7.8 billion people in 2020.
Interventions We correlated CVD with dietary and other risk factors worldwide and in appropriate subsets.
Exposures Dietary and other risk factors
Main Outcome measures CVD versus dietary and other risk factor correlations worldwide and in subsets.
Results We defined a “fat-soluble vitamin variable” (FSVV) as the sum of kilocalories/day (Kcal/day) of processed meat + red meat + fish + milk + poultry + eggs + (saturated fatty acids (SFA) + polyunsaturated fatty acids (PUFA) + trans fatty acids (TFA)) * 0.46. Low density lipoprotein cholesterol (LDL-c) correlated strongly positively with FSVV worldwide (r=0.780, 95% CI 0.771 to 0.788, p<0001, n=7846 cohorts), so we considered FSVV our marker variable to test the lipid hypothesis and our fat-soluble vitamin hypothesis. Both LDL-C and FSVV correlated negatively with CVD worldwide (LDL-C: r= -0.279, 95% CI -0.299 to -0.258, p<0.0001, FSVV: r= -0.329, 95% CI -0.349 to -0.309, p<0.0001). However, FSVV (and not LDL-C) correlated positively with CVD in the highest FSVV cohorts (mean male/female FSVV ≥567.27Kcal/day: r=0.523, 95% CI 0.476 to 0.567, p<0001, n=974 cohorts).
Conclusion and Relevance Since FSVV correlated positively with CVD only in high FSVV cohorts, the lipid hypothesis was supported only in GBD cohorts with high FSVV intake. Since both FSVV and LDL-C correlated negatively with CVD worldwide, only the fat-soluble vitamins hypothesis was supported worldwide, particularly for cohorts with mean male/female FSVV <567.27Kcal/day. A moderate intake of FSVV foods, not yet precisely quantified, is predicted to contribute to reducing CVD risk. This GBD cohort data analysis methodology could be used to help develop food policy and education strategies for improving public health.
Trial Registration N/A
Question Is the lipid hypothesis (i.e., that high dietary saturated fatty acid intake leads to coronary artery disease) valid and/or might low intake of animal foods containing fat-soluble vitamins play a role?
Findings This cohort study supported the lipid hypothesis only in cohorts with high intakes of animal foods and added fats but not worldwide. The fat-soluble vitamin hypothesis was supported in worldwide cohorts.
Meaning The findings suggest that a yet not precisely defined moderate amount of animal food and added fat intake contribute to lower cardiovascular risk relative to very high or very low intakes.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Global burden of disease data was provided by the Institute of Health Metrics and Evaluation for this statistical analysis.
Funding Statement
No external funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No IRB/oversight body approval is needed for the post hoc statistical analysis
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos